PodParley PodParley
PodParley
Ep. 94 / klinische Phase I Studie: bispezifische Antikörper gegen minimale Resterkrankung AML episode artwork

EPISODE · Jun 28, 2024 · 38 MIN

Ep. 94 / klinische Phase I Studie: bispezifische Antikörper gegen minimale Resterkrankung AML

from Leukämie & Tumor Lotse · host Strube-Stiftung

Episode metadata supplied by the publisher feed · Published Jun 28, 2024

Embed this episode

Ready to play

Ep. 94 / klinische Phase I Studie: bispezifische Antikörper gegen minimale Resterkrankung AML

0:00 38:52

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

I Survived 3 Years Of Homelessness Kelly Lay A nervous Breakdown, A Brain Tumor, Spine Disease, Divorce after 28 years of marriage to a verbally, physically abusive drug addict. A son in college, Running Away From Home To Live In An Eco Village (OR 2) Suicidal Ideation, Followed By Actual Homelessness. Then, How I Got Housed And Happy Again

Frequently Asked Questions

How long is this episode of Leukämie & Tumor Lotse?

This episode is 38 minutes long.

When was this Leukämie & Tumor Lotse episode published?

This episode was published on June 28, 2024.

Can I download this Leukämie & Tumor Lotse episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!